Abnova (Taiwan) Corporation Abnova (Taiwan) Corporation

Abnova (Taiwan) Corporation

4133

Rank in Stocks #23947
Abnova (Taiwan) Corporation specializes in the development and distribution of... Abnova (Taiwan) Corporation specializes in the development and distribution of a comprehensive range of recombinant proteins and antibodies. The company's extensive product portfolio caters to diverse research and diagnostic applications, featuring specialized reagents for SARS-CoV/CoV-2, nucleic acids (both DNA and RNA), and various proteins and peptides. Their offerings further include items like DNAxPab, laboratory beads, dyes, cellular lysates, microscopic slides, antibody pairs and associated kits, as well as antibody and tissue arrays. Additionally, they provide in situ hybridization products, advanced laboratory systems and automation, GMP-grade and analyte-specific reagents, and solutions for in vitro diagnostics. Beyond these product lines, Abnova supplies a broad spectrum of antibody types, such as MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, IHC/pathology, and those specifically targeting circulating rare cells. The company also delivers integrated solutions and services, encompassing gene synthesis and cytogenetic analysis, peptide services, protein expression and conjugations, custom antibody generation, and assay development. Abnova (Taiwan) Corporation operates from its headquarters in Taipei, Taiwan.
Share Price
$0.60255961
Last synced: 2026-11-13
Market Cap
$36.49M
Change (1 day)
-0.20%
Change (1 year)
-19.86%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Abnova (Taiwan) Corporation (4133)

Category

Healthcare
EPS for Abnova (Taiwan) Corporation (4133)
EPS as of September 2026 TTM: $0.02
According to Abnova (Taiwan) Corporation's latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of 0.00, a decrease compared to its 2024 EPS of $0.03.
EPS history for Abnova (Taiwan) Corporation from 2009 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.02 -101.93%
2025 0.00 -101.93%
2024 $0.03 32.34%
2023 $0.02 -41.83%
2022 $0.04 137.65%
2021 $0.02 -20.56%
2020 $0.02 1,088.89%
2019 0.00 -92.77%
2018 $0.02 -23.85%
2017 $0.03 16.37%
2016 $0.03 24.89%
2015 $0.02 -32.02%
2014 $0.03 -15.56%
2013 $0.04 -10.30%
2012 $0.04 -31.40%
2011 $0.06 -22.69%
2010 $0.08 50.64%
2009 $0.05 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -4,834.04%
US
$15.66 83,197.87%
US
$-7.07 -37,706.38%
US
$-5.29 -28,238.30%
AU
$12.73 67,624.47%
BE

Questions about Abnova (Taiwan) Corporation's earnings per share (EPS)

What is Abnova (Taiwan) Corporation's earnings per share (EPS)?

Abnova (Taiwan) Corporation's earnings per share (EPS) over the last twelve months is $0.02, as of Sep 2026.

What was Abnova (Taiwan) Corporation's earnings per share (EPS) in 2025?

In 2025, Abnova (Taiwan) Corporation's earnings per share (EPS) was 0.00, compared with $0.03 in 2024.

How has Abnova (Taiwan) Corporation's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Abnova (Taiwan) Corporation's earnings per share (EPS) was highest in 2022 ($0.04) and lowest in 2025 (0.00).

How does Abnova (Taiwan) Corporation's earnings per share (EPS) compare with similar companies?

Abnova (Taiwan) Corporation's earnings per share (EPS) ($0.02) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.